Vetmedin (Pimobendan) for Dogs: Dosage by Weight, MMVD & Heart Failure

Pimobendan is a prescription heart medicine used in dogs with certain forms of heart disease, especially myxomatous mitral valve disease (MMVD) and dilated cardiomyopathy (DCM). It is often known by the brand name Vetmedin, although FDA-approved generic pimobendan products are also available in the United States. Pimobendan is unusual because it works in two useful directions at once: it helps the heart contract more effectively and also reduces some of the resistance the heart must pump against.

Dog Medication Math Calculator

Enter your dog’s current body weight, then use only the dose already provided by your veterinarian or pharmacy label. The calculator converts lb/kg and can work out mg and liquid mL. It does not choose or recommend a dose.

Dose information from your veterinarian

Optional liquid conversion

Use the exact concentration printed on the current bottle. Different refills can have different strengths.
Safety check: This tool performs arithmetic only. It does not decide whether a drug is appropriate, choose a dose, frequency or duration, or replace a veterinarian. If the entered dose or concentration does not exactly match the prescription, stop and verify it before giving medication. See Dog Weight Converter and Dog Liquid Medication mg-to-mL Calculator.

That does not make pimobendan a general “heart tonic.” It is used for specific cardiac problems, at specific disease stages, and usually as one part of a larger treatment plan. A dog with a heart murmur does not automatically need pimobendan, and a dog already taking it may still need other medicines, monitoring, imaging and changes to treatment as the disease progresses.

What pimobendan does

Pimobendan is commonly described as an inodilator. The “ino” part refers to its positive inotropic effect: it can improve the strength of cardiac contraction. The “dilator” part refers to vasodilation, which can reduce vascular resistance. Together, those effects can help the heart move blood more efficiently in selected dogs.

Its pharmacology is more complicated than a single mechanism. Pimobendan increases the sensitivity of cardiac muscle proteins to calcium and also inhibits phosphodiesterase III. For a dog owner, the practical point is simpler: it can improve pumping performance without working like a stimulant in the same way as older positive inotropes.

Which dogs may receive pimobendan?

The best-known uses are canine MMVD and DCM. MMVD is especially common in small and medium-sized older dogs and involves degeneration of the mitral valve, allowing blood to leak backward when the heart contracts. DCM primarily affects the heart muscle and is seen more often in certain larger breeds, although the exact pattern varies.

Pimobendan has an established role in dogs that have developed congestive heart failure from MMVD or DCM. It is also now FDA-approved in the United States to delay the onset of congestive heart failure in dogs with Stage B2 preclinical MMVD. Stage B2 does not simply mean “a murmur is present.” It refers to dogs with MMVD that have measurable heart enlargement and meet specific diagnostic criteria while not yet showing signs of congestive heart failure.

That distinction is important. Starting pimobendan because someone heard a murmur is not the same as starting it after appropriate staging. Veterinarians may use thoracic radiographs, echocardiography, blood pressure, electrocardiography and other tests to decide what type and stage of heart disease is present.

Pimobendan in congestive heart failure

When congestive heart failure develops, pimobendan is usually not used alone. Dogs with fluid accumulation often need a loop diuretic such as furosemide or torsemide. Many treatment plans also include an ACE inhibitor such as enalapril or benazepril and an aldosterone antagonist such as spironolactone. The exact combination depends on the dog, the type of heart disease, kidney function, blood pressure, electrolyte status and response to therapy.

In left-sided congestive heart failure, owners may first notice faster breathing at rest, cough, reduced exercise tolerance, weakness or respiratory distress. In right-sided failure, abdominal fluid accumulation can become more prominent. A dog with breathing difficulty is not a situation for at-home medication experimentation; urgent veterinary assessment is needed.

Vetmedin dosage by weight: what the current U.S. label says

For current U.S. Vetmedin chewable tablets, the labeled total daily amount is 0.5 mg/kg (0.23 mg/lb) body weight. That total is divided into two portions given approximately 12 hours apart. The tablets are half-scored and the veterinarian selects the tablet combination that best matches the calculated prescription.

Body weight exampleLabeled total daily amountAdministration principle
5 kg / 11 lb2.5 mg/dayDivide into two prescribed portions about 12 hours apart
10 kg / 22 lb5 mg/dayDivide into two prescribed portions about 12 hours apart
20 kg / 44 lb10 mg/dayDivide into two prescribed portions about 12 hours apart
40 kg / 88 lb20 mg/dayDivide into two prescribed portions about 12 hours apart

These are label-based examples, not instructions to start pimobendan. Diagnosis and disease stage come first. Two dogs of the same weight can have completely different cardiac problems, including conditions where increasing cardiac output is inappropriate.

Current primary references are the Boehringer Ingelheim Vetmedin prescribing information and the DailyMed label.

How pimobendan is given

Pimobendan is available as chewable tablets and oral solution. Current manufacturer instructions differ by formulation: chewable tablets may be given with food, while the oral solution is administered directly into the mouth and should not be mixed into food. Follow the exact product label and veterinary prescription.

If a dose is missed, the manufacturer advises waiting until the next scheduled dose rather than doubling. See the missed medication dose guide for the broader safety framework.

Why weight alone does not determine whether pimobendan is appropriate

Pimobendan dosing is weight-related, but a calculator cannot determine whether the drug should be used. When a veterinarian has already prescribed a dose and you need help checking units, the Dog Medication Dosage Calculator can verify arithmetic without deciding whether pimobendan is appropriate.

Possible side effects

Many dogs tolerate pimobendan well, but adverse effects can occur. Report vomiting, diarrhea, poor appetite, marked lethargy, weakness or a noticeable change in behavior or activity to the veterinary team. Some signs that occur during heart treatment can also be caused by the underlying disease rather than by pimobendan itself, which is why context matters.

Heart rhythm changes are particularly important to interpret carefully. Dogs with MMVD or DCM may already be predisposed to arrhythmias. If a dog develops collapse, fainting, profound weakness or a suddenly irregular or very rapid heartbeat, veterinary assessment is warranted rather than assuming it is a simple medication side effect.

Can pimobendan cause an overdose?

Yes. Accidental access to a bottle or a dosing error can produce clinically important effects. FDA labeling has specifically emphasized keeping Vetmedin securely out of reach of animals to prevent accidental ingestion or overdose. If a dog receives substantially more than prescribed, call a veterinarian or animal poison service with the product name, strength, number of tablets or volume involved, the dog’s weight and the estimated time of exposure.

Do not wait for severe symptoms if a significant overdose may have occurred. Do not induce vomiting unless a veterinary professional specifically directs you to do so. The appropriate response can depend on how much was swallowed, how long ago it happened and whether the dog already has serious heart disease.

Pimobendan and furosemide

This is a common and purposeful combination in dogs with congestive heart failure. Pimobendan supports cardiac performance, while furosemide helps remove excess sodium and water when pulmonary edema or other fluid accumulation is present. Their roles are different, and one does not substitute for the other.

Owners should understand that the treatment burden of congestive heart failure often comes more from the disease and the diuretic than from pimobendan itself. Increased thirst and urination are expected with loop diuretics, and kidney values and electrolytes may change. That is why dogs on multi-drug heart treatment need follow-up testing.

Pimobendan with enalapril, benazepril or spironolactone

These combinations are also common in canine heart failure. ACE inhibitors such as enalapril or benazepril influence the renin-angiotensin-aldosterone system and can affect blood pressure and kidney perfusion. Spironolactone blocks aldosterone and can influence potassium balance.

The fact that these medicines are often used together does not mean they are interchangeable or risk-free. A dog may need bloodwork after treatment begins or after doses are changed. Kidney disease, dehydration, low blood pressure or electrolyte disturbances can change what is safe.

What monitoring is usually important?

Monitoring varies with disease stage. Dogs with preclinical Stage B2 MMVD may have periodic examinations and repeat imaging to track heart size and function. Dogs with congestive heart failure typically need closer follow-up, particularly after new medicines are started or a diuretic dose is adjusted.

At home, one of the most useful measurements is sleeping or resting respiratory rate. A consistent increase from the dog’s normal baseline can be an early sign that pulmonary congestion is returning. Your veterinarian may provide a threshold or trend that should trigger a call. Record the rate when the dog is genuinely asleep or calmly resting, not immediately after activity or excitement.

Body weight, appetite, energy, coughing, fainting episodes, abdominal enlargement and exercise tolerance can also provide useful information. They do not replace examination or imaging, but a simple home log can make follow-up visits more informative.

Kidney disease, dehydration and low blood pressure

Pimobendan itself is only one part of the risk picture in a dog receiving heart medication. A dog with congestive heart failure may also be taking a diuretic and an ACE inhibitor, both of which can influence kidney perfusion, hydration and blood pressure. Vomiting, diarrhea, poor water intake or a hot day can therefore matter more than they would in a healthy dog taking no cardiovascular medicines.

If a dog on several heart drugs becomes unusually weak, stops eating, vomits repeatedly or appears dehydrated, contact the veterinary team rather than continuing every medicine automatically without guidance. Sometimes the heart still needs treatment while another part of the plan must be adjusted. That judgment requires current examination and, often, bloodwork.

Puppies, breeding dogs and unusual heart disease

Most pimobendan discussions involve adult or older dogs with acquired heart disease, but congenital disease and cardiomyopathy can occur in younger animals. A young dog with a murmur should not be treated as though it has the same condition as an elderly Cavalier King Charles Spaniel with MMVD. Echocardiography can be especially important when congenital structural disease is suspected.

Pregnant or breeding animals also deserve individual veterinary guidance because routine pet-dog information may not address reproductive safety adequately. Do not extrapolate from adult companion-dog dosing to a pregnant, nursing or growing dog without specialist advice.

When to call the veterinarian promptly

Contact the veterinary team if a dog on pimobendan develops repeated vomiting, refuses food, becomes much weaker than usual, faints, has a meaningful increase in resting respiratory rate, develops abdominal swelling, or shows a sudden decline in exercise tolerance. A medication refill should also prompt a question if the tablet strength, appearance, formulation or instructions have changed unexpectedly.

Seek urgent or emergency care for labored breathing, blue or gray gums, collapse, inability to stand, severe weakness, repeated fainting or signs of acute respiratory distress. Do not spend time adjusting heart medicines at home while a dog is struggling to breathe.

Can pimobendan be stopped suddenly?

Do not stop it simply because the dog appears better. Improvement may mean the treatment is working. If side effects are suspected, call the prescribing clinic. In dogs with established heart failure, withdrawing a key medication without a replacement plan can destabilize the condition.

If the medicine is unavailable or a refill is delayed, contact the veterinarian promptly. During past supply shortages, FDA provided specific guidance about approved and imported pimobendan products. Product substitution should be deliberate because formulations and labeling can differ.

Brand-name and generic pimobendan

Vetmedin is the best-known brand. FDA has also approved generic pimobendan products for dogs. An approved generic contains the same active ingredient and must meet regulatory standards for equivalence, but owners should still check the strength, dosage form and dispensing directions when a product changes.

Compounded pimobendan is a separate issue. FDA has noted that compounded products are not FDA-approved and are not evaluated in the same way for safety, effectiveness, manufacturing quality or potency. There can be legitimate reasons for compounding in veterinary medicine, but if an FDA-approved formulation can meet the dog’s needs, discuss the choice with the veterinarian rather than assuming all preparations are identical.

Pimobendan before heart failure: why staging matters

The use of pimobendan before congestive heart failure is not based on the presence of a murmur alone. Stage B2 MMVD requires structural enlargement. A Stage B1 dog can have a murmur and valve disease without enough enlargement to meet B2 criteria. The treatment evidence and regulatory indication are not the same across those stages.

This is one reason echocardiography and thoracic imaging are valuable. They help answer the question that symptoms alone cannot: what is the heart actually doing, and how advanced is the disease?

What pimobendan does not treat

Pimobendan does not remove fluid from the lungs the way a loop diuretic does. It does not correct every arrhythmia. It does not reverse a degenerative mitral valve. It does not replace diagnostic imaging, and it does not make every heart murmur safer.

Heart disease is a category, not a single diagnosis. Congenital defects, pericardial disease, pulmonary hypertension, arrhythmias and systemic illnesses can all produce cardiovascular signs but require different management.

Questions worth asking at the next cardiac visit

Owners often benefit from asking the veterinarian to name the diagnosis and stage rather than only the medicine list. Useful questions include: Is this MMVD, DCM or another condition? Is the dog in congestive heart failure or still preclinical? Which medicine is for fluid control, which supports cardiac performance and which affects blood pressure or neurohormonal activation? What should the dog’s normal sleeping respiratory rate be? When should kidney values and electrolytes be rechecked?

Also ask what changes should trigger an urgent call, whether exercise needs to be modified, and what to do if a dose is missed or vomited. Written instructions reduce errors when several heart medicines are used at different times.

Source quality matters with heart medicines

For pimobendan, strong sources include FDA product information, approved labeling, veterinary cardiology references and peer-reviewed clinical trials. Retailer summaries and informal dosing charts are not equivalent to those sources. DogMedsHub gives preference to regulatory and veterinary references when discussing indications, warnings and treatment context.

For current U.S. regulatory information, see the FDA’s 2025 update on the Stage B2 MMVD indication and the FDA’s information on generic pimobendan approval. For treatment context, the Merck Veterinary Manual heart-failure overview is a useful professional reference.

Bottom line

Pimobendan is an important canine cardiac medicine with a well-established role in selected dogs with MMVD or DCM. It can improve cardiac performance and is used both in congestive heart failure and, for properly staged Stage B2 MMVD, before heart failure develops. The diagnosis, stage and treatment combination matter more than the drug name alone.

If your dog takes pimobendan, know the exact formulation and strength, give it according to the veterinary label, keep it securely stored, monitor the signs your veterinarian has asked you to track and keep follow-up appointments. Do not use an online calculator or another dog’s prescription to decide whether pimobendan is appropriate.

DogMedsHub provides source-backed canine medication guidance and does not diagnose, prescribe or replace veterinary care.

Share